Prevalence of engraftment of maternal T cells in different severe combined immunodeficiency variants
| . | Patients (no.) . | Maternal T-cell engraftment . | |
|---|---|---|---|
| (no.) . | (%) . | ||
| Reticular dysgenesis | 6 | 6 | 100 |
| B− SCID | 26 | 16 | 62 |
| B+ SCID | 52 | 26 | 50 |
| ADA/PNP deficiency | 10 | 0 | 0 |
| MHC class II deficiency | 10 | 0 | 0 |
| Omenn syndrome | 9 | 0 | 0 |
| Absent CD8+ T cells | 5 | 0 | 0 |
| Other T+ SCID | 3 | 0 | 0 |
| All patients | 121 | 48 | 40 |
| . | Patients (no.) . | Maternal T-cell engraftment . | |
|---|---|---|---|
| (no.) . | (%) . | ||
| Reticular dysgenesis | 6 | 6 | 100 |
| B− SCID | 26 | 16 | 62 |
| B+ SCID | 52 | 26 | 50 |
| ADA/PNP deficiency | 10 | 0 | 0 |
| MHC class II deficiency | 10 | 0 | 0 |
| Omenn syndrome | 9 | 0 | 0 |
| Absent CD8+ T cells | 5 | 0 | 0 |
| Other T+ SCID | 3 | 0 | 0 |
| All patients | 121 | 48 | 40 |
SCID indicates severe combined immunodeficiency; ADA, adenosine deaminase; PNP, purine nucleoside phosphorylase; MHC, major histocompatibility complex.